Skip to main content
SpringerLink
Log in

Fluoreszenzzystoskopie

Perspektiven in Klinik und Forschung

Fluorescence cystoscopy

Perspective in clinical practice and research

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Viele Studien bestätigen das klinische Interesse an der photodynamischen Diagnostik (PDD) zur Behandlung des nicht muskelinvasiven Harnblasenkarzinoms. Die PDD oder Fluoreszenzzystoskopie ist bei der Detektion okkulter Urothelkarzinome von großem Wert und mag einen positiven Einfluss auf die rezidivfreie Überlebenszeit und die Prognose haben. Dennoch wird ihre Spezifität mit hoher Variabilität, hauptsächlich in Relation mit den verschiedenen Krankheitsprofilen, in den einzelnen Studien angegeben. Neue Bildgebungstechniken zur Verbesserung der visuellen Beurteilung der Harnblasenwand werden daher entwickelt.

Abstract

Many studies confirm the clinical interest of photodynamic diagnostics (PDD) in non-muscle invasive bladder cancer management. PDD or fluorescence cystoscopy is not only of great value in occult urothelial cancer detection, but may have a positive impact on disease-free survival and prognosis. Yet, its specificity is found to be highly variable between studies mainly in relation to different disease profiles. New imaging techniques aimed at enhancing visualization to assess the bladder wall are under development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Brausi M, Collette L, Kurth KH et al. (2002) Variability in recurrence rate at first follow-up cystoscopy after TUR in stage TaT1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 41: 523–531

    Article  PubMed  Google Scholar 

  2. Baumgartner R, Hofstetter A, Jocham D et al. (1992) Photodynamic diagnosis in urology – first clinical experiences with a new method for detection of early stage cancer. Lasermedizin 16–21

  3. Lange N, Jichlinski P, Zellweger M et al. (1999) Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 80: 185–193

    Article  PubMed  CAS  Google Scholar 

  4. Jocham D, Stepp H, Waidelich R (2007) Photodynamic diagnosis in urology: State-of-the-art. Eur Urol (Epub ahead of print)

  5. Schmidbauer J, Witjes F, Schmeller N, and members of the hexvix PCB301/01 Study Group. (2004) Improved Detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 171: 135–138

    Article  PubMed  Google Scholar 

  6. Jocham D, Witjes F, Wagner S et al. (2005) Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 174: 862

    Article  PubMed  Google Scholar 

  7. Van der Meijden APM, Sylvester R, Oosterlink W et al. (2005) EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur Urol 48: 363–371

    Google Scholar 

  8. Rathert P, Roth S (1993) Indications for urinary cytology. In: Rather P, Roth S, Soloway MS (eds) urinary cytology, manual and atlas, 2nd edn. Springer, Heidelberg Berlin New York, S 9–13

  9. Fradet Y, Loskart C and the ImmunoCyt trialists (1997) Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt™. Can J Urol 3: 400–405

    Google Scholar 

  10. Bubendorf L, Grilli B, Sauter G et al. (2001) Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 116: 79–86

    Article  PubMed  CAS  Google Scholar 

  11. Frampton JE, Plosker GL (2006) Hexyl aminolevulinate in the detection of bladder cancer. Drugs 66: 571–578

    Article  PubMed  CAS  Google Scholar 

  12. Harving N, Wolf H, Melsen F (1988) Positive urinary cytology after tumor resection: an indicator for concomitant carcinoma in situ. J Urol 140: 495–497

    PubMed  CAS  Google Scholar 

  13. Grimbergen MC, van Swol CF, Jonges TG et al. (2003) Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur Urol Jul 44(1): 51–56

    Article  CAS  Google Scholar 

  14. Zaak D, Hungerhuber E, Schneede P et al. (2002) Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer 95(6): 1234–1238

    Article  PubMed  Google Scholar 

  15. Schmidbauer J, Remzi M, Lindenau G et al. (2008) Optical coherence tomography and hexaminolevulinate fluorescence cystoscopy in detecting urothelial carcinoma of the bladder. Eur Urol 7(Suppl 3): 77

    Google Scholar 

  16. Sugano K, Sato K, Yao K (2004) New diagnostic approaches for early detection of gastric cancer. Digest Dis 22(4): 327–333

    Article  Google Scholar 

  17. Shibuya K, H Hoshino, M Chiyo et al. (2002) Subepithelial vascular patterns in bronchial dysplasias using a high magnification bronchovideoscope. Thorax 57(10): 902–907

    Article  PubMed  CAS  Google Scholar 

  18. Bruno MJ (2003) Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosis. Gut 52

  19. Sugano S, Fujinuma S, Sakai Y (2006) Magnifying colonoscopy for the diagnosis of inflammatory changes in ulcerative colitis. Dig Endoscopy 18(3): 173–180

    Article  Google Scholar 

  20. Fortun PJ, Anagnostopoulos GK, Kaye P et al. (2006) Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett’s oesophagus. Aliment Pharmacol Ther 23(6): 735–742

    Article  PubMed  CAS  Google Scholar 

  21. Sasajima K, Kudo SE, Inoue H et al. (2006) Real-time in vivo virtual histology of colorectal lesions when using the endocytoscopy system. Gastrointest Endoscopy 63(7): 1010–1017

    Article  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehung hin: Prof. P. Jichlinski wird ein Konferenzhonorar von GE-Healthcare in 2008 bekommen. Trotz des möglichen Interessenkonflikts ist der Beitrag unabhängig und produktneutral.

Author information

Authors and Affiliations

  1. Universitätsklinik für Urologie, CHUV Hospital, CH-1011, Lausanne, Schweiz

    P. Jichlinski, C. Erling & D. Aymon

  2. Institute of Environmental Engineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Schweiz

    B. Lovisa, H. van den Berg & G. Wagnieres

Authors
  1. P. Jichlinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Lovisa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Erling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Aymon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. van den Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Wagnieres
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Jichlinski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jichlinski, P., Lovisa, B., Erling, C. et al. Fluoreszenzzystoskopie. Urologe 47, 975–977 (2008). https://doi.org/10.1007/s00120-008-1778-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-008-1778-2

Schlüsselwörter

Keywords

Search

Navigation